- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel biomarkers for prognosticating diabetic kidney disease progression ; day:22 ; month:10 ; year:2022 ; pages:1-16
International urology and nephrology ; (22.10.2022), 1-16
- Urheber
-
Swaminathan, Shilna Muttickal
Rao, Indu Ramachandra
Shenoy, Srinivas Vinayak
Prabhu, Attur Ravindra
Mohan, Pooja Basthi
Rangaswamy, Dharshan
Bhojaraja, Mohan V.
Nagri, Shivashankara Kaniyoor
Nagaraju, Shankar Prasad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11255-022-03354-7
- URN
-
urn:nbn:de:101:1-2023010621081626414898
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Swaminathan, Shilna Muttickal
- Rao, Indu Ramachandra
- Shenoy, Srinivas Vinayak
- Prabhu, Attur Ravindra
- Mohan, Pooja Basthi
- Rangaswamy, Dharshan
- Bhojaraja, Mohan V.
- Nagri, Shivashankara Kaniyoor
- Nagaraju, Shankar Prasad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers of diabetic kidney disease
New urinary biomarkers for diabetic kidney disease
Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
Emerging Diabetic Novel Biomarkers of the 21st Century
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophages
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease
Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects
Biomarkers of diabetic kidney disease
New urinary biomarkers for diabetic kidney disease
Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
Emerging Diabetic Novel Biomarkers of the 21st Century
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophages
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease
Multiplatform Metabolomics Reveals Novel Serum Metabolite Biomarkers in Diabetic Retinopathy Subjects
Biomarkers of diabetic kidney disease
New urinary biomarkers for diabetic kidney disease
Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
Emerging Diabetic Novel Biomarkers of the 21st Century
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
Use of novel structural features to identify urinary biomarkers during acute kidney injury that predict progression to chronic kidney disease
A novel role of peroxiredoxin 2 in diabetic kidney disease progression by activating the classically activated macrophages
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease